510(k) Report

510(k) · Cleared

Cleared

BD Directigen EZ Flu a+B Test

K063689510(k) TraditionalCleared Mar 7, 200785-day reviewClass II21 CFR 866.3328

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson & CO · PSZ Devices Detecting Influenza A, B, And C Virus Antigens

Cleared on Mar 7, 2007 as substantially equivalent to K001364 (Bd Becton Dickinson Vacutainer Systems Preanalytic, 2000) and 1 other predicate after an 85-day review. Its family tree reaches back 5 generations to 1990. 2 later devices descend from it.

Decided
Mar 7, 2007
Review
85 days
Class
Class II
Product code
PSZ
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K902609 (1990). 9 ancestors in all. 2 later devices descend from it, 2 citing it directly.

Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 2 other ancestors3 generations back: 1 other ancestor 1 generation forward: 2 descendants K053126 · Binaxnow Influenza a & B Test · Binax, Inc. · 2005K041049 · Binaxnow Influenza a & B Test · Binax, Inc. · 2004K023556 · Flu Oia a/B Test Kit · Thermo Biostar, Inc. · 2003 · recalledK981651 · AB Flu Oia · Biostar, Inc. · 1998K902609 · Directigen Flu a · Bd Becton Dickinson Vacutainer Systems Preanalytic · 1990−50
  1. Root · 5 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. 4 generations backK981651 AB Flu OiaBiostar, Inc. · 1998
  3. 3 generations backK023556 Flu Oia a/B Test KitThermo Biostar, Inc. · 2003 · Recalled
  4. 2 generations backK041049 Binaxnow Influenza a & B TestBinax, Inc. · 2004
  5. 1 generation backK053126 Binaxnow Influenza a & B TestBinax, Inc. · 2005
  6. This deviceK063689 BD Directigen EZ Flu a+B TestBecton, Dickinson & CO · 2007
  7. Descendant · cites it directly · 0 of its ownK101461 BD Directigen EX Flu a+BBecton, Dickinson and Company · 2010
  8. Descendant · cites it directly · 0 of its ownK101529 BD Directigen EZ Flu a+B AssayBecton, Dickinson & CO · 2010

Most influential descendants

Showing 2 of 2 · See all
  • K101461BD Directigen EX Flu a+BBecton, Dickinson and Company · 2010 · cites it directly0descendants
  • K101529BD Directigen EZ Flu a+B AssayBecton, Dickinson & CO · 2010 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K902609Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic1990—
−4K981651AB Flu OiaBiostar, Inc.1998—
−3K023556Flu Oia a/B Test KitThermo Biostar, Inc.20031
−2K041049Binaxnow Influenza a & B TestBinax, Inc.2004—
−1K053126Binaxnow Influenza a & B TestBinax, Inc.2005—
0 (this device)K063689BD Directigen EZ Flu a+B TestBecton, Dickinson & CO2007—
+1K101461BD Directigen EX Flu a+BBecton, Dickinson and Company2010—
+1K101529BD Directigen EZ Flu a+B AssayBecton, Dickinson & CO2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200220

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201020
FIG. 1 — Lineage of K063689, 1990–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSZ device

  1. #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K001364BD Directigen Flu a+B
Summary page 2
…ndow. DEVICE COMPARISON: The BD Directigen EZ Flu A+B test was compared to viral cell culture, direct fluorescent antibody (DFA) tests, the BD Directigen Flu A+B test (K001364) and the Binax NOW Influenza A&B test (K053126). Comparison testing of the BD Directigen EZ A+B test and viral cell culture did n…
Bd Becton Dickinson Vacutainer Systems Preanalytic2000—
*K053126Binaxnow Influenza a & B Test
Summary page 2
…Flu A+B test was compared to viral cell culture, direct fluorescent antibody (DFA) tests, the BD Directigen Flu A+B test (K001364) and the Binax NOW Influenza A&B test (K053126). Comparison testing of the BD Directigen EZ A+B test and viral cell culture did not exhibit any new issues associated with the s…
Binax, Inc.2005—
*—Viral Cell Culture
Named without a submission number
—
*—Direct fluorescent antibody (DFA)
Named without a submission number
—

Also cleared against K001364: 3 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K101461BD Directigen EX Flu a+BBecton, Dickinson and Company20100
K101529BD Directigen EZ Flu a+B AssayBecton, Dickinson & CO20100

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 5 companies; a new generation was cleared every 1.4 years on median.
  • 1 of the 9 ancestors has a recall of any class.
  • Of its descendants, K101461 (Becton, Dickinson and Company, 2010) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K001364.

How does its category compare?

All PSZ devices

PSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · PSZ

2in 2025

2007: 22008: 12009: 72010: 52011: 32012: 22013: 82014: 12015: 42016: 32017: 32018: 52020: 22023: 22025: 22026 (partial year): 2
2007high 8 (2013) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSZ

28in 2018

2009: 20 days median2010: 29 days median2011: 80 days median2013: 28 days median2015: 27 days median2016: 29 days median2017: 200 days median2018: 28 days median
2007high 200 (2017) · low 20 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSZ

1in 2022

2020: 12022: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSZ

60in 2025

2018: 12019: 12020: 52021: 422022: 102023: 122024: 162025: 60
2007high 60 (2025) · low 0 (2007)2025

MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200972000
201052900
201138000
20122—00
201382800
20141—00
201542700
201632900
2017320000
201852801
20190—01
20202—15
20210—042
20220—110
20232—012
20240—016
20252—060
20262—0—

What is it indicated for?

The BD DirectigenTM EZ Flu A+B test is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral antigens from nasopharyngeal washes/aspirates, nasopharyngeal swabs and throat swabs of symptomatic patients. The BD Directigen EZ Flu A+B test is a differentiated test, such that influenza A viral antigens can be distinguished from influenza B viral antigens from a single processed sample using a single device.…

Read the full statement (157 words)

The BD DirectigenTM EZ Flu A+B test is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral antigens from nasopharyngeal washes/aspirates, nasopharyngeal swabs and throat swabs of symptomatic patients. The BD Directigen EZ Flu A+B test is a differentiated test, such that influenza A viral antigens can be distinguished from influenza B viral antigens from a single processed sample using a single device. The test is to be used as an aid in the diagnosis of influenza A and B viral infections. All negative test results should be confirmed by cell culture because negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions.

Performance characteristics for Influenza B using nasopharyngeal swabs (NPS) were established primarily with retrospective, frozen specimens. Users may wish to establish the sensitivity of this test for Influenza B using fresh nasopharyngeal swab specimens.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K063689: BD Directigen EZ Flu a+B Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K063689

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026